Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

BACKGROUND: The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In spite of this, the activity of CDK4/6 inhibitors in patients with metastatic breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Demir, Atakan, Mandel, Nil Molinas, Paydas, Semra, Demir, Gökhan, Er, Özlem, Turhal, Nazım Serdal, Bavbek, Sevil, Eralp, Yeşim, Saip, Pınar Mualla, Güler, Emine Nilüfer, Aydıner, Adnan, Oyan Uluç, Başak, Kılıçkap, Sadettin, Üskent, Necdet, Karadurmuş, Nuri, Kaplan, Mehmet Ali, Yanmaz, Mustafa Teoman, Demir, Hacer, Alan, Özkan, Korkmaz, Taner, Olgun, Polat, Sönmez Uysal, Özlem, Altundağ, Kadri, Gündüz, Şeyda, Günaldı, Meral, Sarı, Murat, Beypınar, İsmail, Başaran, Gül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094190/
https://www.ncbi.nlm.nih.gov/pubmed/31970972
http://dx.doi.org/10.4274/balkanmedj.galenos.2020.2019.11.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094190/
https://www.ncbi.nlm.nih.gov/pubmed/31970972
http://dx.doi.org/10.4274/balkanmedj.galenos.2020.2019.11.143

Ejemplares similares